AR039691A1 - Formas de dosificacion solidas farmaceuticas - Google Patents

Formas de dosificacion solidas farmaceuticas

Info

Publication number
AR039691A1
AR039691A1 ARP030102145A ARP030102145A AR039691A1 AR 039691 A1 AR039691 A1 AR 039691A1 AR P030102145 A ARP030102145 A AR P030102145A AR P030102145 A ARP030102145 A AR P030102145A AR 039691 A1 AR039691 A1 AR 039691A1
Authority
AR
Argentina
Prior art keywords
weight
ethanomidoylamino
thio
antioxidant
ethyl
Prior art date
Application number
ARP030102145A
Other languages
English (en)
Original Assignee
Sb Pharmco Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sb Pharmco Inc filed Critical Sb Pharmco Inc
Publication of AR039691A1 publication Critical patent/AR039691A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Otolaryngology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

Se describen composiciones farmacéuticas que comprenden (2S)-2-amino-4-{[2-(etanomidoilamino)etil]tio}butanoico, de fórmula general (1): un agente de relleno farmacéuticamente aceptable y uno o más agentes antioxidantes o quelantes. Reivindicación 6: Una composición farmacéutica de acuerdo con una cualquiera de las reivindicaciones 1 a 5, en la que el ácido (2S)-2-amino-4-{[2-(etanomidoilamino)etil]tio}butanoico comprende de aproximadamente un 0,1 a aproximadamente un 5% en peso, el agente de relleno farmacéuticamente aceptable comprende de aproximadamente un 80 a aproximadamente un 99,5% en peso y el agente antioxidante y quelante, o mezcla de los mismos comprende de aproximadamente un 0,005 a aproximadamente un 5% en peso, con respecto al peso seco. Reivindicación 12: Uso de una composición farmacéutica de acuerdo con cualquiera de las reivindicaciones 1 a 8 en la fabricación de un medicamento para la profilaxis o tratamiento de una afección clínica para la que está indicado un inhibidor de la óxido nítrico sintasa. Reivindicación 13: Uso de acuerdo con la reivindicación 12, en la que la afección clínica se selecciona entre artritis, asma, rinitis, enfermedad pulmonar obstructiva crónica, íleo, migrana, dolor y síndrome del intestino irritable.
ARP030102145A 2002-06-19 2003-06-17 Formas de dosificacion solidas farmaceuticas AR039691A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0214147.1A GB0214147D0 (en) 2002-06-19 2002-06-19 Formulations

Publications (1)

Publication Number Publication Date
AR039691A1 true AR039691A1 (es) 2005-03-09

Family

ID=9938915

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP030102145A AR039691A1 (es) 2002-06-19 2003-06-17 Formas de dosificacion solidas farmaceuticas

Country Status (8)

Country Link
US (1) US20050222260A1 (es)
EP (1) EP1513511A1 (es)
JP (1) JP2005533075A (es)
AR (1) AR039691A1 (es)
AU (1) AU2003278958A1 (es)
GB (1) GB0214147D0 (es)
TW (1) TW200404766A (es)
WO (1) WO2004000296A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1750675B1 (en) * 2004-06-02 2008-10-29 Galephar M/F Stable oral pharmaceutical compositions of buprenorphine and salt thereof
WO2011052499A1 (ja) * 2009-10-28 2011-05-05 第一三共株式会社 貯蔵安定性が改善された医薬組成物
DE102011051304A1 (de) * 2011-06-24 2012-12-27 Hennig Arzneimittel Gmbh & Co. Kg Wirkstoffmatrix
CN102908323B (zh) * 2012-10-30 2015-03-04 天津红日药业股份有限公司 一种含有莫西沙星的药物组合物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ289157A (en) * 1994-06-15 1998-03-25 Wellcome Found Amidino sulphoxides and sulphones; medicaments for selective inhibition of inducible nitric oxide synthase
CA2194371A1 (en) * 1994-07-04 1996-01-18 Thomas Backensfeld Low-dose steroid tablets containing gallic acid esters as antioxidant agent, process for the manufacture of said tablets, and uses of said tablets
FR2753098B1 (fr) * 1996-09-06 1998-11-27 Sod Conseils Rech Applic Composition pharmaceutique comprenant au moins un inhibiteur de no synthase et au moins un piegeur des formes reactives de l'oxygene
MY117948A (en) * 1997-01-13 2004-08-30 Glaxo Group Ltd Nitride oxide synthase inhibitors.
GB0031179D0 (en) * 2000-12-21 2001-01-31 Glaxo Group Ltd Nitric oxide synthase inhibitors

Also Published As

Publication number Publication date
EP1513511A1 (en) 2005-03-16
AU2003278958A1 (en) 2004-01-06
JP2005533075A (ja) 2005-11-04
TW200404766A (en) 2004-04-01
GB0214147D0 (en) 2002-07-31
US20050222260A1 (en) 2005-10-06
WO2004000296A1 (en) 2003-12-31

Similar Documents

Publication Publication Date Title
CO4950524A1 (es) Inhibidores de acido nitrico sintasa
HN2005000484A (es) Nuevas composiciones farmaceuticas para el tratamiento de trastornos hiperproliferativos
AR063555A1 (es) Derivados de androstano, su uso en la fabricacion de medicamentos, composiciones farmaceuticas que los comprenden y procesos para prepararlos
BR0111206A (pt) Derivados de arilmetilamina para uso como inibidores de triptase
CO5640076A2 (es) Composicion farmaceutica que comprende un inhibidor de ibat para el tratamiento o profilaxis del estreñimiento
BR0213612A (pt) Composto, composição farmacêutica, uso do composto e método para tratamento de doença ou condição
NO20082000L (no) Pyrimidinamidforbindelser som PGDS-inhibitorer
BR9611015A (pt) Composto, composição farmacêutica e processo para o tratamento de uma doença inflamatória suscetìvel ao tratamento com um agente não-tóxico anti-inflamatório não-esteróide, sal farmaceuticamente aceitável, utilização de um composto
BR0212378A (pt) Inibidores de 17beta-hidroxiesteróide desidrogenase tipo 3 para o tratamento de doenças dependentes de androgênio
BR0208489A (pt) Derivados de n-(arilsulfonil) beta-aminoácidos, comportando um grupo aminoetilado substituìdo, o respectivo processo de preparação e as composições farmacêuticas que os contêm
AR027528A1 (es) Preparacion farmaceutica para el tratamiento de rinitis alergica y/o vasomotriz o conjuntivitis alergica, la utilizacion de dicha preparacion para laobtencion de medicamentos y el procedimiento para preparar dichos medicamentos
AR020727A1 (es) Uso de compuestos derivados 3-amino-4-aril-maleimidas para la preparacion de medicamentos para condiciones asociadas a una necesidad de inhibicion de lagsk-3, dichos compuestos, procedimiento para su preparacion y composiciones farmaceuticas que los comprenden
HRP20050663A2 (en) Malonamide derivatives as gamma-secretase inhibitors
BRPI0415437A (pt) composto, processo para a preparação e uso do mesmo, composição farmacêutica, processo para a preparação da mesma, e, produto
NO20090327L (no) Nye forbindelser 384
CY1108900T1 (el) Πολυθειωμενα γλυκοζιδια και αλατα αυτων
BRPI0509720A (pt) derivados de 4-alquil- e 4-alcanoil-piperidina substituìda e seu uso como antagonistas de neurocinina
UY28979A1 (es) Derivados de hidrocloruros de 3-carboxamida, composiciones farmacéuticas que los contienen, procedimiento de preparación y su uso, útiles como inhibidores selectivos de gsk3
CL2004000590A1 (es) Compuestos derivados de 1,3,4-oxadiazol-3-ona, 1,3,4-tiadiazol-2-ona y de 1,2,4-triazol-3-ona; composicion farmaceutica que los contiene; procedimiento de preparacion y su uso en la preparacion de un medicamento en los que esta relacionado el virus v
PE20070828A1 (es) Composicion farmaceutica que contiene una sal de glicopirronio
AR037931A1 (es) Metodo para granulacion humeda de azitromicina
BR112023000560A2 (pt) Compostos inovadores como inibidor de histona desacetilase 6 e composição farmacêutica que compreende os mesmos
BR0210207A (pt) Derivados de pirrolidina como inibidores do fator xa
CO5011084A1 (es) Composiciones y metodos para tratar trastornos respiratorios
BR9911274A (pt) Derivados da artemisinina, seus processos de preparação e as composições farmacêuticas que os contêm

Legal Events

Date Code Title Description
FB Suspension of granting procedure